Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets.

Authors:
Kazeminasab F; Baharlooie M; Ghaedi K.

Journal:
PPAR Res

Publication Year: 2022

DOI:
10.1155/2022/6161694

PMCID:
PMC9509273

PMID:
36164476

View on PubMed View on PMC View Publisher
Journal Information

Full Title: PPAR Res

Abbreviation: PPAR Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Appraisal of the Possible Role of PPAR<i>γ</i> Upregulation by CLA of Probiotic <i>Pediococcus pent…
Dubey V; Mishra AK; Ghosh AR. (2023) - Transparency Score: 3/6
A Promotion Role of MIR31 in the Process of Vocal Fold Wound Healing.
Wang H; Xu W. (2023) - Transparency Score: 3/6
Buspirone Induces Weight Loss and Normalization of Blood Pressure via the Stimulation of PPAR<i>δ</…
Lee YJ; Kim HM; Jang YN and 6 more (2023) - Transparency Score: 3/6
Comprehensive Analysis Identifies the PPAR-Targeted Genes Associated with Ovarian Cancer Prognosis …
Leng XF; Wang GF; Yin H and 3 more (2023) - Transparency Score: 3/6
Effect of Pesticides on Peroxisome Proliferator-Activated Receptors (PPARs) and Their Association w…
Hernández-Valdez J; Velázquez-Zepeda A; Sánchez-Meza JC. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that there is no conflict of interest regarding the publication of this article."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025